Elevation Spine Secures FDA Clearance for Saber-C AVIA
MONTEREY, Calif., July 29, 2026 Elevation Spine has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Saber-C®...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MONTEREY, Calif., July 29, 2026 Elevation Spine has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Saber-C®...
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
Westminster, Colorado | April 24, 2026 Cerapedics has announced a strategic supplier agreement with Vizient, significantly expanding access to...
DURHAM, N.C., April 2, 2026 restor3d, Inc., a leader in 3D-printed orthopedic medical devices, announced the full commercial release...
BESANÇON, France, March 24, 2026 Pixee Medical has announced the U.S. launch of its Knee+ NexSight augmented reality (AR)...
Dateline – FORT LAUDERDALE, Fla., Feb. 5, 2026 — Spinal Resources Inc. announced that the U.S. Food and Drug...
UNITED STATES | January 27, 2026 — ABANZA, a medical technology company focused on advancing soft-tissue fixation solutions, announced...
